Johnson & Johnson also terminated a trial of its own tau-targeting antibody, posdinemab, in late 2025
n-decyl -D-maltopyranoside
Helixara Eterna C NAD + Methylene Blue + Resveratrol System 1030 mg (500+30+500) NAD (500 mg), Methylene Blue (30 mg), and Resveratrol (500 mg) Helixara ReCode N Epitalon + MNM 310 mg (1+300) Support studies on cellular longevity, mitochondrial activation, and circadian regulation Helixara TirzeCode rx40 | rx60 40 mg 60 mg High-purity Tirzepatide (40 mg) in sterile research-grade format Helixara clat C3 Gluthatione +Vit.C + GHK-Cu Peptide Glutathione 1000mg +Vit.C 1000mg + GHK-Cu Peptide 100mg Glutathione (1000 mg), Vitamin C (1000 mg), and GHK-Cu Peptide (100mg) Helixara MOTS-c Research Peptide 20 mg High-purity MOTS-c peptide (20 mg) in sterile cartridge +injection pen format, studied in relation to metabolic signaling and mitochondrial pathways.
Worth Noting BPC-157 has one of the broadest research profiles of any peptide available
The absolute bioavailability observed after IM administration of each dose in dogs was 45.27%, 47.64%, and 50.56%, respectively
